Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Cipro
Generic name / active ingredient
ciprofloxacin
Dosage-form class
Oral tablets: 250 mg, 500 mg; oral suspension: 250 mg/5 mL, 500 mg/5 mL(as listed in the 2026 DailyMed label)
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • Check CIPRO, ciprofloxacin, exact dosage form and strength together. Milligrams on a tablet and the concentration, measuring device and volume of an oral suspension are not the same information; a shared generic name or nearby number does not support self-conversion from “tablets” to “millilitres” or assembling different forms into one plan.
  • The FDA label carries dedicated warnings about important serious fluoroquinolone adverse reactions, including nervous-system and tendon-related concerns. With older age, prior reactions, multiple medicines, or new pain, sensory, mental or neurologic symptoms, take the actual package and complete medicine list for timely professional assessment; do not use this page to decide continuation, increase, stopping or a change.
  • “Both antibacterials” or “both used for urinary/respiratory infection” does not establish that products can be taken together, alternated, shared with family or substituted. Infection site, testing, prior treatment, kidney function, other medicines and the current label all need item-by-item review by the prescribing team.
  • Package photos, colours and this page’s source link only help identify what is being read; they cannot authenticate a medicine, decide whether an antibacterial is needed or replace assessment of acute illness. With severe or rapidly worsening illness, allergy-related symptoms or uncertainty about use, use local medical-support pathways.

Reviewed presentation examples — compare every field

  • 500 mg per tablet; 100-tablet bottleNDC 50419-754-01
  • 250 mg per 5 mL; 100 mL reconstituted oral-suspension kitNDC 50419-777-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image